Skip to content

Prospective observational study of the treatment and prognosis in patients with previously untreated indolent B cell lymphoma

Prospective observational study of the treatment and prognosis in patients with previously untreated indolent B cell lymphoma - FLSG09

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000010175
Enrollment
200
Registered
2013-03-11
Start date
2015-01-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Indolent B-cell Non-Hodgkin&#39

Interventions

None listed

Sponsors

Fukuoka Lymphoma Study Group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)MATURE B-CELL NEOPLASMS Small lymphocytic lymphoma Splenic B-cell marginal zone lymphoma Lymphoplasmacytic lymphoma Extranodal marginal zone lymphoma of mucosa-associate lymphoid tissue (MALT lymphoma) Nodal marginal zone lymphoma Follicular lymphoma 2)Measurable lesions>=1.5cm by CT scan

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Characteristics and prognosis in patients with indolent B-cell Non-Hodgkin's lymphoma.

Countries

Japan

Contacts

Public ContactKoji Kato

Fukuoka Lymphoma Study Group FLSG-2010

fbmtg@intmed1.med.kyushu-u.ac.jp092-642-5230

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026